Pfizer Inc. (PFE)
27.09
+0.17
(+0.63%)
USD |
NYSE |
Apr 13, 10:24
Pfizer Free Cash Flow : 9.076B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 9.456B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.349B |
| Cash from Investing (Quarterly) | -6.146B |
| Cash from Financing (Quarterly) | 596.00M |
| Free Cash Flow Per Share (Quarterly) | 0.7921 |
| Free Cash Flow to Equity (Quarterly) | -1.20B |
| Free Cash Flow to Firm (Quarterly) | 5.214B |
| Free Cash Flow Yield | 5.87% |